Exhibit 99.2

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

On August 21, 2020, Vyant Bio, Inc. (formerly known as Cancer Genetics, Inc.) (the “Company” or “VYNT”) entered into an Agreement and Plan of Merger and Reorganization, as amended (the “Merger Agreement”) between the Company, StemoniX, Inc., a Minnesota corporation (“StemoniX”), and CGI Acquisition, Inc., a Minnesota corporation and wholly-owned subsidiary of the Company (“Merger Sub”), which as amended was approved by the stockholders of the Company on March 24, 2021, pursuant to which Merger Sub merged with and into StemoniX, with StemoniX surviving the merger and becoming a direct, wholly-owned subsidiary of the Company (the “merger”). All dollar amounts, except per share, are in thousands.

The unaudited pro forma condensed combined financial information is presented to illustrate the estimated effects of the merger between StemoniX and VYNT based on the historical financial position and results of operations of StemoniX and VYNT. It is presented as follows:

While VYNT was the legal acquirer, the merger is accounted for as a reverse acquisition using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) Topic 805, “Business Combinations” (“ASC 805”). StemoniX is deemed to be the acquirer for financial accounting purposes. The unaudited pro forma condensed combined financial information set forth below primarily gives effect to the following:

Collectively, the above noted StemoniX Series C Preferred, PIPE and the RD Financing satisfied a merger-related requirement for fund raising. These financings did not impact the targeted ownership formulas in the Merger Agreement and the dilution from these transactions were realized proportionately by the pre-merger Vyant and StemoniX shareholders based on the final ownership structure of approximately 19.7% and 80.3%, respectively.

Assumptions underlying the pro forma adjustments are described in the accompanying notes, which should be read in conjunction with the unaudited pro forma condensed combined financial information. The unaudited pro forma combined balance sheet data gives effect to the merger as if it had occurred on December 31, 2020. The unaudited pro forma combined statement of operations data for the year ended December 31, 2020 gives effect to the merger as if it had occurred on January 1, 2020.

The unaudited pro forma condensed combined financial information has been prepared using the acquisition method of accounting under existing GAAP, which is subject to change. StemoniX is deemed the accounting acquirer in the merger for accounting purposes and VYNT is treated as the acquiree, based on a number of factors considered at the time of preparation of this Current Report on Form 8-K (this “Form 8-K), including control over the post-merger company as evidenced by the composition of executive management and the board of directors as well as the relative equity ownership after the closing of the merger. The application of acquisition accounting of VYNT is dependent upon the working capital positions at the closing of the merger and on other factors such as the share price of VYNT as well as certain valuations and other studies that have yet to progress to a stage where there is sufficient information for a definitive measurement. The combined company will complete the valuations and other studies upon completion of the merger and will finalize the purchase price allocation as soon as practicable within the measurement period, but in no event later than one year following the closing date of the merger. The assets and liabilities of VYNT and other pro forma adjustments have been measured based on various preliminary estimates using assumptions that VYNT and StemoniX believe are reasonable, based on information that is currently available. Accordingly, the pro forma adjustments are preliminary. Differences between these preliminary estimates and the final acquisition accounting could be significant, and these differences could have a material impact on the accompanying unaudited pro forma condensed combined financial information and the combined company’s future results of operation and financial position.

The unaudited pro forma condensed combined financial information has been compiled in a manner consistent with the accounting policies adopted by StemoniX. Upon completion of the merger, the combined company will perform a detailed review of VYNT’s accounting policies and will conform the combined company policies. The combined company may identify additional differences between the accounting policies of the two companies that, when conformed, could have a material impact on the consolidated financial statements of the combined company. Additionally, certain financial information of VYNT as presented in its historical consolidated financial statements has been reclassified to conform to the historical presentation in StemoniX’s financial statements for purposes of preparation of the unaudited pro forma condensed combined financial information. Transactions between StemoniX and VYNT during the periods presented in the unaudited pro forma condensed combined financial information were not significant.

This unaudited pro forma condensed combined financial information was derived from and should be read in conjunction with the accompanying notes, as well as the following historical financial statements and the related notes of StemoniX and VYNT:

UNAUDITED PRO FORMA COMBINED BALANCE SHEET

AS OF DECEMBER 31, 2020

(thousands in USD)

See accompanying notes to the unaudited pro forma condensed combined financial information.

UNAUDITED PRO FORMA COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2020

(thousands in USD except per share amounts)

See accompanying notes to the unaudited pro forma condensed combined financial information.

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

(thousands in USD)

1. Description of the Merger

On August 21, 2020, VYNT, StemoniX and Merger Sub entered into the Merger Agreement, as subsequently amended. Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into StemoniX, with StemoniX surviving the merger as a wholly owned subsidiary of VYNT. For financial reporting and accounting purposes, StemoniX was the acquirer of VYNT upon completion of the merger.

In consideration for the merger, taking into account 4,434,733 shares of common stock of VYNT (including 94,092 shares issuable upon the cash exercise of certain warrants issued to the placement agent in VYNT’s public offering that closed on November 2, 2020 the (“November PA Warrants”) and in-the-money common stock options and warrants) that were deemed outstanding immediately prior to the closing of the merger (excluding 6,670,886 shares of VYNT common stock issued in VYNT Merger Financings), (i) the shares of StemoniX common stock (after the conversion to StemoniX Common Stock of all preferred stock (except for the Series C Preferred Stock) and convertible notes) and in-the-money warrants (excluding the Convertible Note Warrants) that were issued and outstanding immediately prior to the effective time were converted into an aggregate of 17,277,991 shares of common stock of VYNT, (ii) StemoniX options issued and outstanding immediately prior to the effective time were exchanged for options to purchase 893,179 shares of VYNT common stock and (iii) the warrants to purchase StemoniX common stock issued in connection with certain convertible notes (“Convertible Note Warrants”) issued and outstanding immediately prior to the effective time were exchanged for warrants to purchase an aggregate of 143,890 shares of VYNT common stock. In addition, shares of StemoniX Series C Preferred issued and outstanding immediately prior to the effective time were converted into an aggregate of 699,395 shares of VYNT common stock. An aggregate of 6,670,886 shares of VYNT common stock were also outstanding from the VYNT Merger Financings. Furthermore, certain assumptions related to financing arrangements and the settlement of certain obligations with third parties that have yet to be effectuated have been assumed.

The Merger Agreement provided for net cash targets of $2,000 for VYNT and $500 for StemoniX. As a result of the merger and the final net cash target settlement on the merger closing date, the holders of equity interests of StemoniX as of immediately prior to the merger effective time (other than with respect to the Series C Preferred Stock) now own approximately 80.3% of the outstanding shares of the common stock of the combined company, and the pre-merger outstanding (i) shares of VYNT common stock (including underlying in-the-money VYNT options and VYNT warrants on a net exercise basis) excluding the VYNT securities issued in the PIPE and RD Financing and (ii) shares underlying the then exercisable November PA Warrants represented approximately 19.7% of the outstanding shares of the common stock of the combined company (which outstanding shares, the “Deemed Outstanding Shares”, in this context, means the shares of VYNT common stock outstanding, plus (i) any shares of VYNT common stock issuable on a net exercise basis with respect to any in-the-money VYNT options or in-the-money VYNT warrants (excluding the November PA Warrants), in-the-money StemoniX options and in-the-money StemoniX warrants (excluding the Convertible Note Warrants) and (ii) the amount of shares of VYNT common stock issuable upon cash exercise of the November PA Warrants and Convertible Note Warrants, but reduced by the securities issued in the PIPE and the RD Financing and the Series C Preferred shares) pursuant to the Merger Agreement. The intent of the foregoing is that the PIPE, the RD Financing and the issuance of the StemoniX Series C Preferred shares diluted all other holders proportionately.

2. Basis of Presentation

The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release No. 33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses.” Release No. 33-10786 replaces the existing pro forma adjustment criteria with simplified requirements to depict the accounting for the transaction (“Transaction Accounting Adjustments”) and present the reasonably estimable synergies and other transaction effects that have occurred or are reasonably expected to occur (“Management’s Adjustments”). Only Transaction Accounting Adjustments in the following unaudited pro forma condensed combined financial information. The historical financial information has been adjusted in the accompanying unaudited pro forma condensed combined financial information to give effect to unaudited pro forma events that are:

The condensed pro forma financial information includes certain financing transactions completed by both VYNT and StemoniX prior to the merger that were in order to attempt to meet the net cash targets defined in the Merger Agreement to meet the targeted ownership structure of 22% and 78%, respectively, and also the issuance of StemoniX Series C Preferred shares and securities of VYNT in the VYNT Merger Financings.

The merger is treated as a business combination for accounting purposes, with StemoniX as the deemed accounting acquirer and VYNT as the deemed accounting acquiree. Therefore, the historical basis of StemoniX’s assets and liabilities will not be remeasured as a result of the merger. In identifying StemoniX as the acquiring entity, the companies considered the structure of the merger, relative outstanding share ownership at closing and the composition of the combined company’s board of directors and senior management.

The unaudited pro forma condensed combined financial information was prepared using the acquisition method of accounting in accordance with ASC 805, which requires, among other things, that assets acquired and liabilities assumed in a business combination be recognized at their fair values as of the acquisition date. The acquisition method of accounting uses the fair value concepts defined in ASC Topic 820, “Fair Value Measurement” (“ASC 820”). Fair value is defined in ASC 820 as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Market participants are assumed to be buyers or sellers in the most advantageous market for the asset or liability. Fair value measurement for an asset assumes the highest and best use by these market participants.

Fair value measurements can be highly subjective, and it is possible the application of reasonable judgment could develop different assumptions resulting in a range of alternative estimates using the same facts and circumstances.

Fair value estimates were determined based on preliminary discussions between StemoniX and VYNT management, and a preliminary valuation of VYNT’s assets and liabilities using December 31, 2020 as the measurement date. The allocation of the aggregate merger consideration used in the preliminary unaudited pro forma condensed combined financial information is based on preliminary estimates. The estimates and assumptions are subject to change as of the effective time of the merger. The final determination of the allocation of the aggregate merger consideration will be based on the actual tangible and intangible assets and the liabilities of VYNT at the effective time of the merger. Refer to Note 5 for additional information.

For pro forma purposes, the valuation of consideration transferred is based on, among other things, the number of VYNT common shares outstanding and the closing price per share of $4.61 as of March 30, 2021 (the merger closing date), and the fair value of common share stock options and warrants outstanding at such date. Refer to Note 5 for additional information.

The unaudited pro forma combined balance sheet data gives effect to the merger as if it had occurred on December 31, 2020. The unaudited pro forma combined statement of operations data gives effect to the merger as if it had occurred on January 1, 2020. The pro forma financial information also excludes the discontinued operations reported in VYNT historical consolidated statement of operations and other comprehensive loss for year ended December 31, 2020.

The unaudited pro forma condensed combined financial information is presented solely for informational purposes and is not necessarily indicative of the combined results of operations or financial position that might have been achieved for the period or date indicated, nor is it necessarily indicative of the future results of the combined company. The unaudited pro forma condensed combined financial information has not been adjusted to give effect to certain expected financial benefits of the merger, such as tax savings, cost synergies or revenue synergies, or the anticipated costs to achieve these benefits, including the cost of integration activities. The unaudited pro forma condensed combined financial information does not reflect possible adjustments related to restructuring or integration activities that have yet to be determined or transaction or other costs following the combination that are not expected to have a continuing impact on the business of the combined company, one-time transaction-related expenses anticipated to be incurred prior to, or concurrent with, the closing of the merger are included in the unaudited pro forma combined statement of operations. The impact of such transaction expenses is reflected in the unaudited pro forma combined balance sheet as a decrease to cash and increase to accumulated deficit.

3. Accounting Policies

The unaudited pro forma condensed combined financial information has been compiled in a manner consistent with the accounting policies of StemoniX. Following the merger, the combined company will conduct a review of accounting policies of VYNT in an effort to determine if differences in accounting policies require further reclassification of results of operations or reclassification of assets or liabilities to conform to StemoniX’s accounting policies and classifications. As a result of that review, the combined company may identify differences among the accounting policies of the companies that, when conformed, could have a material impact on the unaudited pro forma condensed combined financial information.

4. VYNT Reclassifications

Certain financial information of VYNT has been reclassified to conform to the historical presentation in StemoniX’s financial statements as set forth below:

Revenue is broken down by product revenues and service revenues to conform to StemoniX’s statement of operations presentation. As VYNT is a service company, all revenues are classified as service revenues. VYNT’s service revenues were $5,751 for the year ended December 31, 2020.

Cost of goods sold is broken down by product and service to conform to StemoniX’s statement of operations presentation. Cost of goods sold reflected in VYNT’s consolidated statements of operations are classified as service cost of goods sold. VYNT’s cost of goods sold - service was $3,353 for the year ended December 31, 2020.

VYNT’s accrued expenses of $1,028 were reclassified from Accounts payable and accrued to Accrued expenses to conform to StemoniX’s balance sheet presentation.

General and administrative expenses as well as sales and marketing expenses were reclassified from their original classification to conform to StemoniX’s statements of operations presentation. VYNT’s general and administrative expenses were $6,595 for the year ended December 31, 2020. VYNT’s sales and marketing expenses were $1,246 for the year ended December 31, 2020.

5. Reverse acquisition and purchase price allocation

Fair Value of Total Consideration Transferred

The fair value of preliminary purchase consideration expected to be transferred on the closing date includes the value of the number of shares of the combined company to be owned by VYNT shareholders at closing of the merger and the fair value of common share stock options and warrants outstanding (“Share-based Instruments”) at such date. The fair value per share of VYNT’s common stock used for the preliminary purchase price allocation was $4.61 per share the closing price of VYNT common stock on March 30, 2021, the effective date of the merger.

Purchase Price Allocation

The following is a preliminary estimate of the allocation of the purchase price to acquired identifiable assets and assumed liabilities, which includes preliminary purchase accounting adjustments to reflect the fair value of intangible assets acquired at the time of the merger:

The intangibles identified relate to customer lists and tradename. The valuation is internally developed, and these are valued on a preliminary basis. Changes in fair values could result in material adjustments in the purchase price allocation and resulting goodwill.

The preliminary estimated fair value of intangibles of $8,700, which is an increase of $8,700 from VYNT’s book value of intangible assets prior to the merger. The acquired identified intangible assets are expected to be comprised of the following:

The fair value estimate for all identifiable intangible assets is preliminary and is based on assumptions that market participants would use in pricing an asset, based on the most advantageous market for the asset (i.e., its highest and best use). This preliminary fair value estimate could include assets that are not intended to be used, may be sold, or are intended to be used in a manner other than their best use. The final determination of fair value of intangible assets, as well as estimated useful lives, remains subject to change. The finalization may have a material impact on the valuation of intangible assets and the purchase price allocation, which is expected to be finalized subsequent to the merger. A 10% change in the valuation of intangible assets would cause a corresponding increase or decrease to goodwill of approximately $870 at the merger date and a corresponding decrease to amortization expense of approximately $870 for the year ended December 31, 2020, assuming an overall weighted-average useful life of 10 years.

6. Unaudited Pro Forma Combined Balance Sheet Adjustments

The following provides explanations of the various adjustments to the unaudited pro forma combined balance sheet:

7. Unaudited Pro Forma Statement of Operations Adjustments

The following provides explanations of the various adjustments to the unaudited pro forma combined statement of operations:

8. Loss per Share

The unaudited pro forma weighted average number of basic and diluted shares outstanding for the year ended December 31, 2020 is calculated as follows:

The unaudited pro forma weighted average number of basic shares outstanding is calculated by adding the number of combined company shares expected to be issued to the stockholders of StemoniX after giving effect to the pre-closing StemoniX conversions and the historical weighted average number of basic shares of VYNT, which will remain outstanding as shares in the combined company on a 1:1 basis. The pro forma adjusted weighted average shares outstanding in thousands is 27,612 shares for the year ended December 31, 2020.